Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models (Q92750308)
Jump to navigation
Jump to search
scientific article published on 16 July 2019
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models |
scientific article published on 16 July 2019 |
Statements
Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models (English)
Mark Anderton
Andrew Bailey
Scott Boyd
Joanna Brookfield
Ceri Cairnduff
Mark Charles
Anne Cheasty
Susan E Critchlow
Janet Culshaw
Tennyson Ekwuru
Ian Hollingsworth
Neil Jones
Fred Leroux
Hollie McCarron
Jennifer McKelvie
Lorraine Mooney
David Perkins
Steve Powell
Mar Jimenez Quesada
Piotr Raubo
Verity Sabin
James Smith
Andrew Stark
Attilla Ting
Peng Wang
Zena Wilson
Jon J Winter-Holt
J Matthew Wood
Gail L Wrigley
Guoqing Yu